AdvaMed, Abbott ask FDA to prioritize cybersecurity, PCCP and LDT guidances next year
Regulatory NewsFerdous Al-Faruque
Artificial intelligence/machine learning (AI/ML)Diagnostics/IVDsGuidanceLaboratory developed tests (LDTs)Medical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)